Loading...
Pieris Pharmaceuticals, Inc

Project Description

CEO: Stephen S. Yoder, J.D.
Headquarters: Boston, Massachusetts
URL: www.pieris.com
Investment Date: December 2014
APO Financing: $13,600,000
Trading Venue: NASDAQ CM (PIRS)

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary AnticalinĀ® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

INVESTORS

COLLABORATIONS

COMPANIES WE HAVE FUNDED